Navigation Links
ADHD Drug Shortage Has Patients, Parents Scrambling
Date:5/12/2011

By Amanda Gardner
HealthDay Reporter

WEDNESDAY, May 11 (HealthDay News) -- Due to an ongoing shortage, some American adults with attention-deficit hyperactivity disorder (ADHD), or the parents of children with ADHD, are having to call multiple pharmacies before finding one that carries the prescription they need to manage the condition.

Accounts of exactly which drugs are affected vary, but much of the focus has been on Adderall XR, made by Shire PLC, and its two generic versions, also made by Shire but distributed by drug companies Teva and Impax.

However, generic versions of the widely used ADHD drugs Ritalin and Concerta have also been affected, Valerie Jensen, associate director of the drug shortages program at the U.S. Food and Drug Administration, told the Wall Street Journal on Tuesday.

Although the shortage doesn't seem severe and, according to industry representatives, should be over by the end of the month, not having the pills can cause significant disruptions to patients' lives.

According to Matt Cabrey, a spokesman for Shire PLC, which makes Adderall XR, the "supply interruption" is due both to higher demand and to the fact that the Drug Enforcement Administration (DEA) didn't deliver enough of the active ingredient in Adderall XR, amphetamine, to the company. Amphetamine is a controlled substance and strictly regulated by the DEA.

For its part, drug maker UCB SA, which makes generic versions of methylphenidate, said its shortages stem from a spike in consumer demand early in 2011. The company hopes to be able to meet consumer demand for its products by May 20, spokeswoman Brenda Varney told the WSJ.

Novartis AG, which also sells generic versions of methylphenidate via its Sandoz unit, told the newspaper that it is also having trouble keeping up with market demand.

As the shortage continues, "Families who are resourceful and able to call around to multiple pharmacies will often find what they need -- but often is not always," said Dr. Andrew Adesman, chief of developmental and behavioral pediatrics at the Steven and Alexandra Cohen Children's Medical Center of New York, in New Hyde Park. "In some households, it may not pose a major hardship if they have a short-term disruption in terms of medical treatments, but in some households it can prove a hardship."

One problem: these medicines typically stop working almost as soon as the patient stops using them. Interruption at this particular time -- when the school year is winding down -- could be especially hard for youngsters who rely on their medications to perform academically, Adesman pointed out.

"It could also lead to significant untoward effects behaviorally in the classroom," he said.

According to Adesman, patients (or their parents) should first check with different pharmacies to see if another one has the prescription they need.

"If that doesn't work, have a dialogue with your doctor," said Dr. Lenard A. Adler, director of the Adult ADHD Program at NYU Langone Medical Center in New York City.

There may be reasonable alternatives but they can be a mixed blessing.

Switching drugs isn't always an option. In some cases it can be difficult to translate dosing to another medication, since generics can have subtle differences from brand name drugs.

In the case of Adderall XR, this shouldn't be a problem because the same company manufactures both the brand name and the two generics, noted Shire PLC spokesman Cabrey.

Then there's the financial implications. Switching from a brand-name drug to a generic could save money but going from a generic to a brand name could have the opposite effect on the pocketbook.

There could also be financial repercussions if an insurance company doesn't cover the temporary substitute.

For example, one woman ended up having to pay $140 a month for a new medication, more than twice her previous $60 co-pay, according to the Wall Street Journal.

Some patients may be able to switch from long-lasting pills to short-acting ones but that would mean taking several pills a day instead of just one, Adler said.

Cutting back on doses will have an impact on ADHD symptoms. "They will decrease their improvement if they cut back on their doses," said Adler.

The main thing, said Adler is to "be sure you don't stop your medicine. The impairments of having untreated ADHD are significant."

More information

There's more on ADHD treatments at the U.S. National Institute of Mental Health.

SOURCES: Matt Cabrey, spokesman, Shire PLC, Wayne, Pa.; Andrew Adesman, M.D., chief, developmental and behavioral pediatrics, Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park; Lenard A. Adler, M.D., director, Adult ADHD Program, NYU Langone Medical Center, New York City; May 10, 2011, Wall Street Journal


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. No End In Sight To The Armour Thyroid Shortage?
2. Website for Nursing Jobs Launches -- Streamlined Job Board Created to Address Nursing Shortage
3. Shortage of Black Doctors Rooted in Social, Economic Ills
4. Primary Care Physician Shortage: Texas Tech University Health Sciences Center Has the Solution
5. International summit seeks solutions to global shortage of nursing faculty
6. HCL Thames Medics says more locum doctors could help address European Working Time Directive shortage
7. Scottsdale Veterinary Pharmacy Celebrates Success in Business By Dodging Veterinary Drug Shortages
8. Shortage of Transplant Organs Spurs Proposals But No Solution
9. Decline in international medical graduates exacerbates shortage of general surgeons
10. SNM cautions that Canadas Chalk River coming back online will not solve long-term isotope shortage
11. Vitamin D Shortage Not Tied to Stroke Deaths in Blacks: Study
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
ADHD Drug Shortage Has Patients, Parents Scrambling
(Date:12/4/2016)... , ... December 03, 2016 , ... While James Earl ... serving as host for in a show called "Front Page". One of the forthcoming ... years, breast cancer rates have plummeted in large part due to early detection. Like ...
(Date:12/4/2016)... Washington DC (PRWEB) , ... December 04, 2016 , ... ... Environmental, one of the most certified and experienced Indoor Air Quality Companies in VA, ... Assessment and Remediation Regulations. , The new mold law in the district ...
(Date:12/2/2016)... ... December 02, 2016 , ... On Dec. 2, 2016, CURE® magazine ... San Diego honoring the 2016 MPN Heroes—eight individuals who have made a difference in ... and beyond the standard of care, demonstrating leadership within the MPN community and/or a ...
(Date:12/2/2016)... ... 2016 , ... Center for Autism and Related Disorders (CARD) Portland today announced ... disorder (ASD) and other developmental disabilities. The group, which is being launched with the ... the opportunity to share stories and advice, seek help, and continue their education on ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... California, will be included in the 2016 “Guide to America’s Top Plastic Surgeons” ... on the amalgamation of their education, experience, and professional associations. , One ...
Breaking Medicine News(10 mins):
(Date:12/4/2016)... 3, 2016 Johnson & Weaver, LLP announces that ... of Zimmer Biomet Holdings, Inc. (NYSE: ZBH ) ... 31, 2016 (the "Class Period"). Zimmer Biomet provides ... orthopaedic reconstructive products, such as knee and hip reconstructive products. ... , , ...
(Date:12/4/2016)...   Pairnomix, LLC, a genetic research company and ... the White House, today announced that findings from its first ... candidate therapies for a patient with epileptic encephalopathy caused by ... at the 70 th Annual Meeting of the ... , December 2-6, 2016.  Pairnomix, unique process involves ...
(Date:12/4/2016)...  Results from the Phase II SUSTAIN study show ... the median annual rate of sickle cell-related pain crises ... p=0.010) in patients with or without hydroxyurea therapy 1 ... featured in the official press briefing at the 58 ... and presented during the Plenary Scientific Session tomorrow (Abstract ...
Breaking Medicine Technology: